NHS

News

NICE rejects J&J's Darzalex regimen for multiple myeloma

New guidance from NICE has rejected a combination regimen based on Johnson & Johnson's Darzalex for a group of previously-untreated patients with multiple myeloma, a type of bone marrow

Patients

Blueprints for UK pharma-NHS joint working

Joint working could hold at least part of the answer to getting the NHS back on its feet after COVID, according to the ABPI.

News

Digital-health-is-not-about-big-data–it-is-about-people

NHS data sharing scheme "on hold" as millions opt out

The NHS' much-vaunted GP data-sharing initiative looks to be on a prolonged hiatus, with at least one report suggesting it has been hit by 1.2 million people choosing to opt out of the sche

News

UK adults asked to record coughs to improve COVID detection

Researchers in the UK are asking adults who have taken a COVID-19 test in the last 72 hours to record themselves coughing, breathing and speaking to help develop new ways to detect infectio

Views & Analysis

A problem combination?

Leela Barham takes stock of past NICE decisions for combinations to explore the scale of the reimbursement challenge for combination therapies.

News

NICE changes stance on Lilly's breast cancer dug Verzenios

After rejecting Eli Lilly's Verzenios for breast cancer therapy earlier this year, NICE has relented, recommending the drug for routine NHS use alongside hormonal therapy fulvestrant.

NICE rejects J&J's Darzalex regimen for multiple myeloma

Blueprints for UK pharma-NHS joint working

NHS data sharing scheme "on hold" as millions opt out

UK adults asked to record coughs to improve COVID detection

A problem combination?

NICE changes stance on Lilly's breast cancer dug Verzenios

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

NHS

Editor's Picks